Clinical Trials Directory

Trials / Completed

CompletedNCT03146312

Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health

Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Gene Expression, Epigenetics and Nutritional Status in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
USANA Health Sciences · Industry
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is a global transcriptomics and epigenetic pilot study designed to identify changes in gene expression and DNA methylation patterns following the consumption of an MVM/phytochemical supplement in a small group of healthy subjects. We hypothesize that genome-wide transcriptional and epigenetic studies will elucidate the molecular mechanisms underlying the health benefits associated with MVM/phytochemical supplementation.

Detailed description

There is considerable controversy regarding the benefit of widespread dietary supplement use, in particular widespread MVM use. The controversy persists because of a marked incongruity in nutrition research: on one hand, many studies indicate that MVM supplement consumption yields few - if any - demonstrable health benefits, yet on the other hand, numerous findings indicate most Americans do not consume the RDA of a variety of nutrients, particularly vitamins and minerals, and are becoming increasingly under-nourished. Nutrigenomics offers a unique opportunity to address this controversy, as it can identify subtle changes in gene expression and epigenetic signatures immediately following a nutritional intervention - changes which may be indicative of improved health status and which may otherwise remain undetectable through other clinical endpoints for a considerable period of time, even into future generations. Hypothesis: The investigators hypothesize that MVM/phytochemical supplementation will result in transcriptional and epigenetic changes consistent with an enhancement in human health status. Moreover, the investigators hypothesize that MVM/phytochemical supplementation will alter markers of cardiovascular, antioxidant, nutritional as well as inflammatory status in a manner indicative of improved health. Study Design: This will be a randomized, double blind, placebo controlled, parallel arm design conducted over a 4-week period. 50-60 healthy subjects will be recruited and, if eligible for the study, matched by age, sex and ethnicity and randomized in a 1:1 ratio to either of two interventions: 1. Daily consumption of the control supplement (placebo) 2. Daily consumption of the MVM/phytochemical supplement (treatment) Methods: Blood will be collected at baseline and after the 4-week intervention. At each time point, PBMCs will be collected, and DNA and RNA extracted for genome-wide gene expression and DNA methylation analyses. Serum and plasma will also be collected in order to assess clinical markers related to cardiovascular, nutritional, antioxidant and inflammatory status.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMVM/phytochemical supplementConsumption of an MVM/phytochemical supplement for 4 weeks
DIETARY_SUPPLEMENTPlaceboConsumption of a placebo tablet identical in size, shape and color to the treatment tablet

Timeline

Start date
2017-04-20
Primary completion
2017-06-08
Completion
2017-06-08
First posted
2017-05-09
Last updated
2018-03-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03146312. Inclusion in this directory is not an endorsement.